D-OCT for Detection and Subtyping of BCC: a Diagnostic Cohort Study

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Feb 15, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to diagnose basal cell carcinoma (BCC), which is a common type of skin cancer. Currently, doctors usually take a small sample of the affected skin (a biopsy) to examine it under a microscope. This trial is exploring whether a non-invasive imaging technique called dynamic optical coherence tomography (D-OCT) can accurately detect BCC and determine its subtype, which is important because different types of BCC require different treatments. For example, some types can be treated with creams, while others may need to be surgically removed.

To participate in this study, you must be 18 years or older and have skin lesions that doctors suspect may be non-melanoma skin cancer. You should also be able to undergo both a D-OCT scan and a biopsy as part of your regular care. If you decide to join the trial, you can expect to have these tests done to help researchers understand how well D-OCT works compared to traditional methods. The trial is not yet recruiting participants, but it aims to improve how BCC is diagnosed, which could lead to better treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18+ years
• • Lesions suspect for non-melanoma skin cancer or premalignancy
• • Patient underwent D-OCT scan and biopsy conform regular care
• Exclusion Criteria:
• • Patient unable to sign informed consent.